Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Bu-Yeo Kim
Introduction
Bu-Yeo Kim is a prominent inventor based in Seoul, South Korea. He has made significant strides in the field of pharmaceuticals, particularly in the treatment of malignant tumors. His work focuses on utilizing genetic components to develop effective therapies for cancer patients.
Latest Patents
Bu-Yeo Kim holds a patent for a pharmaceutical composition aimed at treating malignant tumors. This composition includes a human p31 gene encoding protein, which has been shown to suppress cancer cell growth, induce apoptosis, and effectively kill cells by overexpressing p31 in solid malignant tumor cells. This innovative approach offers promising potential for gene therapy in oncology.
Career Highlights
Kim is affiliated with the Korea Institute of Radiological and Medical Sciences, where he conducts research and development in medical technologies. His contributions to the field have been recognized for their potential impact on cancer treatment and patient care.
Collaborations
Some of his notable coworkers include Kee-Ho Lee and Sang-Hoon Kim, who collaborate with him on various research projects aimed at advancing medical science.
Conclusion
Bu-Yeo Kim's innovative work in developing pharmaceutical compositions for cancer treatment highlights the importance of genetic research in modern medicine. His contributions are paving the way for new therapeutic options for patients battling malignant tumors.